Delivery Order SPE2DB22D3301-SPE2DB25FY9DP
- Not listed
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,293.75 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4561772238 units of AKYNZEO 300-0.5 mg capsules. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order, issued under an unspecified agency-level contract vehicle, requires shipment of the pharmaceutical products to the agency by August 11,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 21, 2025, for AKYNZEO 300-0.5 mg capsules with a ceiling value of $5,541.20. This firm fixed-price, non-competitive set-aside contract is funded by the Medical Supply Chain division of the Department of Defense and is scheduled for completion by August 22, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $729,981.18 by the Defense Logistics Agency's Medical Supply Chain on November 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $782,486.45 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $27,577.00 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $14,651.24 by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $31,726.08 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price contract, awarded on August 2, 2025, with an ultimate completion date of August 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order valued at $45,541.02 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitive award, which carries no set-aside designation, is structured as a firm fixed-price delivery order and represents a child contract under the company's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,995.98 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. This competitive award, issued under a firm fixed-price contract type, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9DPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for AKYNZEO 300-0.5 mg capsules valued at $5,541.20. This competitively awarded, firm fixed-price delivery order, issued on August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The medication is being delivered to the Conshohocken, Pennsylvania location, with a completion date of August 12, 2025. This delivery order reflects AmerisourceBergen's role as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, supplying pharmaceutical products to support military and federal healthcare systems. The award falls under the company's comprehensive pharmaceutical prime vendor agreement, which enables the delivery of a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains. As a non-set-aside award, this contract was competed among qualified vendors and demonstrates AmerisourceBergen's continued capability to fulfill federal medical procurement requirements efficiently and competitively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/11/25 |